Trial
NCT03465345
Study of Metformin Plus Oligomeric Procyanidin Complex for Pharmacologic Manipulation of AGE (Advanced Glycation Endproducts) Levels in Prostate Cancer Patients
Phase IWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Medical University of South Carolina
Collaborators
—
Condition
Prostate Cancer
Intervention
Metformin
Why stopped
Study was stopped to pursue a new treatment plan with a new study.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-08-03